Michael Blowhard cites Michael Eades on the recent statin news:
Let’s look at [the study] in the best light possible. If we do, we find that a small group of unusual patients — those with low LDL-cholesterol and high C-reactive protein — may slightly decrease their risk for all-cause mortality by taking a drug that costs them almost $1,300 per year and slightly increases their risk for developing diabetes. That’s the best spin possible given the data from this study. Compare that to the spin the media is giving it.